Latest Schedule 13G passive stakes

FMR LLC and Abigail P. Johnson have reported a significant beneficial ownership stake of 10.3% in Remitly Global Inc. as of June 30, 2026.

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 10,201,685 shares, representing 7.9% of SkinHealth Systems Inc.'s Class A Common Stock as of June 30, 2026.

FMR LLC and Abigail P. Johnson have filed a Schedule 13G, reporting beneficial ownership of 1,800 shares of Centessa Pharmaceuticals PLC common stock as of June 30, 2026.

FMR LLC, through its subsidiaries, has disclosed beneficial ownership of 1.9% of Nuvalent Inc.'s Class A Common Stock as of June 30, 2026.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 10.5% in South Bow Corp's common stock as of June 30, 2026.

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 2,886,891.70 shares of EchoStar Corp's Class A Common Stock, representing 1.8% of the class.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 4.0% of Apogee Therapeutics Inc.'s common stock as of June 30, 2026.

Truist Financial Corporation, through its advisory arm, has reported beneficial ownership of 54,280 shares in the Calamos ETF Trust, representing 8.4% of the class.

Truist Financial Corporation, through its advisory arm, reports beneficial ownership of 274,293 shares in Pacer Funds Trust, representing 26.8% of the class.

Truist Financial Corporation, through its advisory arm, has disclosed beneficial ownership of 1,446,446 shares, representing 5.6% of the outstanding shares in the iShares Trust Exchange Traded Fund.

Polar Capital Holdings Plc, Polar Capital LLP, and Polar Capital Funds PLC report a beneficial ownership of 4.80% in Verastem, Inc.

FMR LLC, through its subsidiaries, reports beneficial ownership of 25.7% of Cerebras Systems Inc. Class A Common Stock as of June 30, 2026.

Truist Financial Corporation, through its advisory arm, has disclosed beneficial ownership of 131,344 shares, representing 7.6% of the outstanding class of securities in Victory Portfolios II.

Truist Financial Corporation, through its advisory arm, has disclosed beneficial ownership of 1,063,157 shares, representing 5.3% of the outstanding class of securities in the Victory Portfolios II Exchange Traded Fund.

Truist Financial Corporation, through its advisory arm, has disclosed beneficial ownership of 258,597 shares in ETF Opportunities Trust, representing 6.3% of the class.

Allspring Global Investments Holdings, LLC has increased its beneficial ownership of Mayville Engineering Co Inc common stock to 4.2%, acquiring 1,072,916 shares.

Cohen & Steers, Inc. and its affiliates have updated their beneficial ownership filing for UDR, Inc., reporting a combined stake of 4.77% in the company's common stock as of June 30, 2026.

Cohen & Steers, Inc. and its affiliates have updated their beneficial ownership filing for UDR, Inc., reporting a combined stake of 4.77% in the company's common stock as of June 30, 2026.

Cohen & Steers, Inc. and its affiliates have filed a Schedule 13G, reporting beneficial ownership of 5,769,920 shares of Kilroy Realty Corp. common stock, representing 4.96% of the class.

Cohen & Steers, Inc. and its affiliates have filed a Schedule 13G, reporting beneficial ownership of 5,769,920 shares of Kilroy Realty Corp. common stock, representing 4.96% of the class.

Cohen & Steers, Inc. and its affiliates have filed a Schedule 13G, reporting beneficial ownership of Empire State Realty Trust, Inc. common stock.

Cohen & Steers, Inc. and its affiliates have filed a Schedule 13G, reporting beneficial ownership of Empire State Realty Trust, Inc. common stock.

Federated Hermes, Inc. and associated entities report a 4.45% beneficial ownership stake in SCYNEXIS Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and associated entities report a 4.45% beneficial ownership stake in SCYNEXIS Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and related entities have filed a Schedule 13G, reporting beneficial ownership of 4.15% of Ovid Therapeutics Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and related entities have filed a Schedule 13G, reporting beneficial ownership of 4.15% of Ovid Therapeutics Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and associated entities have filed a Schedule 13G, reporting beneficial ownership of 17.17% of Minerva Neurosciences, Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and associated entities have filed a Schedule 13G, reporting beneficial ownership of 17.17% of Minerva Neurosciences, Inc. common stock as of June 30, 2026.

Federated Hermes, Inc. and associated entities report a beneficial ownership stake of 4.59% in MGP Ingredients, Inc. as of June 30, 2026.

Federated Hermes, Inc. and associated entities report a beneficial ownership stake of 4.59% in MGP Ingredients, Inc. as of June 30, 2026.